MIF and neoplasm: In sum, our therapeutic proof-of-principle CRC mouse models show that tumor-specific stabilized MIF contributes to tumor-associated macrophage recruitment and vessel formation to maintain colorectal tumors, creating a vulnerability which provide a potential targeting strategy in CRC therapies.